2009
DOI: 10.1152/ajpheart.01130.2008
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelaxation

Abstract: Nitric oxide (NO) inhibits transient receptor potential channel 3 (TRPC3) channels via a PKG-dependent mechanism. We sought to determine 1) whether NO inhibition of TRPC3 occurs in freshly isolated smooth muscle cells (SMC); and 2) whether NO inhibition of TRPC3 channels contributes to NO-mediated vasorelaxation. We tested these hypotheses in freshly isolated rat carotid artery (CA) SMC using patch clamp and in intact CA by vessel myograph. We demonstrated TRPC3 expression in whole CA (mRNA and protein) that w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
42
1

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 74 publications
(50 citation statements)
references
References 31 publications
7
42
1
Order By: Relevance
“…TRPC3 and TRPC6 are known to heterotetramerize based on immunoprecipitation and fluorescence resonance energy transfer studies (26). Genetic models involving expression of dominant negative proteins (8) may induce a promiscuous effect on the other channel and other TRPC channels; for instance, TRPC1 also multimerizes with TRPC3 (27). The present study supports this hypothesis, because neither single gene deletion model ameliorated hypertrophy/dysfunction with TAC, whereas the dKO model was more effective.…”
Section: Discussionsupporting
confidence: 75%
“…TRPC3 and TRPC6 are known to heterotetramerize based on immunoprecipitation and fluorescence resonance energy transfer studies (26). Genetic models involving expression of dominant negative proteins (8) may induce a promiscuous effect on the other channel and other TRPC channels; for instance, TRPC1 also multimerizes with TRPC3 (27). The present study supports this hypothesis, because neither single gene deletion model ameliorated hypertrophy/dysfunction with TAC, whereas the dKO model was more effective.…”
Section: Discussionsupporting
confidence: 75%
“…The effect of combined application of TRPV1 and TRPA1 antagonists on OA-NO 2 -evoked currents was comparable with that of the reducing agent DTT that competitively reacts with the electrophilic fatty acid (Salazar et al, 2008;Chen et al, 2009). Thus, the action of DTT on the OA-NO 2 -evoked currents is highly suggestive of an electrophilic interaction of OA-NO 2 with cysteine residues of TRP channels, such as that reported for various pungent compounds and AITC (Hinman et al, 2006;Macpherson et al, 2007).…”
supporting
confidence: 58%
“…1C). While this molecular weight does not correspond to the generally reported values of around 100 kDa [25], it is close to the isoform of TRPC1 detected in rat neurons [26]. Indeed, a short isoform has already been detected via RT-PCR in salivary gland cells [27] or in immature CD34 + cells [14] and shown to disappear and be progressively replaced by the unspliced TRPC1 form during that differentiation into megacaryocytes [14].…”
Section: Resultscontrasting
confidence: 46%